Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 2
2018 1
2019 3
2020 1
2021 1
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass.
Stillger MN, Kurowski K, Bronsert P, Brombacher E, Kreutz C, Werner M, Tang L, Timme-Bronsert S, Schilling O. Stillger MN, et al. Among authors: timme bronsert s. Int J Cancer. 2024 Jun 15;154(12):2162-2175. doi: 10.1002/ijc.34867. Epub 2024 Feb 14. Int J Cancer. 2024. PMID: 38353498
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer.
Thomsen AR, Sahlmann J, Bronsert P, Schilling O, Poensgen F, May AM, Timme-Bronsert S, Grosu AL, Vaupel P, Gebbers JO, Multhoff G, Lüchtenborg AM. Thomsen AR, et al. Among authors: timme bronsert s. Front Oncol. 2023 Dec 19;13:1275222. doi: 10.3389/fonc.2023.1275222. eCollection 2023. Front Oncol. 2023. PMID: 38169879 Free PMC article.
Oncological recurrence following pathological complete response after neoadjuvant treatment in patients with esophageal cancer - a retrospective cohort study.
Hipp J, Kuvendjiska J, Hillebrecht HC, Herrmann S, Timme-Bronsert S, Fichtner-Feigl S, Hoeppner J, Diener MK. Hipp J, et al. Among authors: timme bronsert s. Langenbecks Arch Surg. 2023 Sep 18;408(1):363. doi: 10.1007/s00423-023-03100-2. Langenbecks Arch Surg. 2023. PMID: 37721586 Free PMC article.
Benchmarking of analysis strategies for data-independent acquisition proteomics using a large-scale dataset comprising inter-patient heterogeneity.
Fröhlich K, Brombacher E, Fahrner M, Vogele D, Kook L, Pinter N, Bronsert P, Timme-Bronsert S, Schmidt A, Bärenfaller K, Kreutz C, Schilling O. Fröhlich K, et al. Among authors: timme bronsert s. Nat Commun. 2022 May 12;13(1):2622. doi: 10.1038/s41467-022-30094-0. Nat Commun. 2022. PMID: 35551187 Free PMC article.
Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
Petrova E, Wellner J, Nording AK, Braun R, Honselmann KC, Bolm L, Hummel R, Klinkhammer-Schalke M, Zeissig SR, Kleihues van Tol K, Timme-Bronsert S, Bronsert P, Zemskov S, Keck T, Wellner UF. Petrova E, et al. Among authors: timme bronsert s. Cancers (Basel). 2021 Dec 4;13(23):6121. doi: 10.3390/cancers13236121. Cancers (Basel). 2021. PMID: 34885230 Free PMC article.
Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma.
Petrova E, Zielinski V, Bolm L, Schreiber C, Knief J, Thorns C, Bronsert P, Timme-Bronsert S, Bausch D, Perner S, Keck T, Wellner U. Petrova E, et al. Among authors: timme bronsert s. Virchows Arch. 2020 Apr;476(4):561-568. doi: 10.1007/s00428-019-02719-1. Epub 2019 Nov 30. Virchows Arch. 2020. PMID: 31786688
Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives.
Martini V, Timme-Bronsert S, Fichtner-Feigl S, Hoeppner J, Kulemann B. Martini V, et al. Among authors: timme bronsert s. Cancers (Basel). 2019 Oct 26;11(11):1659. doi: 10.3390/cancers11111659. Cancers (Basel). 2019. PMID: 31717773 Free PMC article. Review.
15 results